171 related articles for article (PubMed ID: 23471783)
21. First and second trimester immune biomarkers in preeclamptic and normotensive women.
Taylor BD; Ness RB; Klebanoff MA; Zoh R; Bass D; Hougaard DM; Skogstrand K; Haggerty CL
Pregnancy Hypertens; 2016 Oct; 6(4):388-393. PubMed ID: 27939488
[TBL] [Abstract][Full Text] [Related]
22. [Cell-free DNA fraction: Can it be used to evaluate the risk of obstetrical issues?].
Duvillier C; Quibel T; Felsenheld C; Hupin-Genty L; Cohen C; Vialard F
Gynecol Obstet Fertil Senol; 2019 Nov; 47(11):790-796. PubMed ID: 31593819
[TBL] [Abstract][Full Text] [Related]
23. MR-proANP, a cardiovascular biomarker to predict late-onset preeclampsia and intrauterine growth restricted fetuses.
Birdir C; Fox L; Droste L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
Pregnancy Hypertens; 2020 Oct; 22():54-58. PubMed ID: 32739718
[TBL] [Abstract][Full Text] [Related]
24. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
25. Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction.
Vasku M; Kleine-Eggebrecht N; Rath W; Mohaupt MG; Escher G; Pecks U
Pregnancy Hypertens; 2018 Jan; 11():7-11. PubMed ID: 29523277
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy.
Ferguson KK; McElrath TF; Chen YH; Mukherjee B; Meeker JD
Am J Reprod Immunol; 2014 Sep; 72(3):326-36. PubMed ID: 24807462
[TBL] [Abstract][Full Text] [Related]
27. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.
Schoofs K; Grittner U; Engels T; Pape J; Denk B; Henrich W; Verlohren S
J Perinat Med; 2014 Jan; 42(1):61-8. PubMed ID: 23929878
[TBL] [Abstract][Full Text] [Related]
28. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
[TBL] [Abstract][Full Text] [Related]
29. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
[TBL] [Abstract][Full Text] [Related]
30. Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction.
Kwak DW; Kim SY; Kim HJ; Lim JH; Kim YH; Ryu HM
Sci Rep; 2020 Jul; 10(1):11848. PubMed ID: 32678284
[TBL] [Abstract][Full Text] [Related]
31. Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction.
Onalan R; Onalan G; Gunenc Z; Karabulut E
Gynecol Obstet Invest; 2006; 61(3):142-8. PubMed ID: 16374017
[TBL] [Abstract][Full Text] [Related]
32. Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial.
García B; Llurba E; Valle L; Gómez-Roig MD; Juan M; Pérez-Matos C; Fernández M; García-Hernández JA; Alijotas-Reig J; Higueras MT; Calero I; Goya M; Pérez-Hoyos S; Carreras E; Cabero L
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):680-9. PubMed ID: 26823208
[TBL] [Abstract][Full Text] [Related]
33. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction.
Yu N; Cui H; Chen X; Chang Y
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048
[TBL] [Abstract][Full Text] [Related]
34. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction.
Illanes S; Parra M; Serra R; Pino K; Figueroa-Diesel H; Romero C; Arraztoa JA; Michea L; Soothill PW
Prenat Diagn; 2009 Dec; 29(12):1118-22. PubMed ID: 19816882
[TBL] [Abstract][Full Text] [Related]
35. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
[TBL] [Abstract][Full Text] [Related]
37. Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia.
Barneo-Caragol C; Martínez-Morillo E; Rodríguez-González S; Lequerica-Fernández P; Vega-Naredo I; Álvarez FV
Free Radic Biol Med; 2019 Jul; 138():1-9. PubMed ID: 31055131
[TBL] [Abstract][Full Text] [Related]
38. The impact of female fetal sex on preeclampsia and the maternal immune milieu.
Taylor BD; Ness RB; Klebanoff MA; Tang G; Roberts JM; Hougaard DM; Skogstrand K; Haggerty CL
Pregnancy Hypertens; 2018 Apr; 12():53-57. PubMed ID: 29674199
[TBL] [Abstract][Full Text] [Related]
39. Predictive Role of First-trimester ELABELA Levels for Late-onset Preeclampsia.
Ozgen G; Aydin GA; Ayvaci H
J Coll Physicians Surg Pak; 2021 Aug; 31(8):916-920. PubMed ID: 34320707
[TBL] [Abstract][Full Text] [Related]
40. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
